Cutia Therapeutics
Status: Publicly traded
Direct answer
Cutia Therapeutics is publicly traded on HKSE under the ticker 2487.HK.
Cutia Therapeutics is a biopharmaceutical firm dedicated to establishing a robust dermatology platform for addressing conditions affecting both the skin and scalp. Its comprehensive therapeutic scope encompasses various dermatological challenges, including medications for localized fat accumulation, advanced care for scalp disorders, treatments for a wide array of skin ailments, and topical pain management. Founded...
Can you invest in Cutia Therapeutics?
Yes. Cutia Therapeutics trades publicly on HKSE as 2487.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cutia Therapeutics
Detailed equity research is provided by MarketSnap.